Danielle is a la Caixa INPhINIT Fellow at ISGlobal. Her main subject areas include HIV, hepatitis C and harm reduction. Her doctoral work focuses on how to make harm reduction centers more responsive to the needs of women who inject drugs.
Previously, Danielle was a Research Assistant on the Health Systems Research Group at ISGlobal where she focused on health system responses to hepatitis C and HIV.
Before her time at ISGlobal, she provided research assistance for the Care and Policy Evaluation Centre, Public Health England, and the International Initiative for Impact Evaluation.
She holds a Bachelor's degree in Health and Societies from the University of Pennsylvania and a Master's degree in Global Health Policy from the London School of Economics and Political Science.
Lines of research
- Hepatitis C
- Harm reduction
- Kall M., Fresán U., Guy D. et al. Quality of life in people living with HIV in Romania and Spain. BMC Infect Dis 21, 898 (2021). https://doi.org/10.1186/s12879-021-06567-w.
- Lazarus, J., Picchio C., Guy D., Aleman S., James C., Nava F., Øvrehus A., Turnes J., Ward J., Ustianowski A. Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy. Clinics and Research in Hepatology and Gastroenterology, Volume 45, Issue 2, 2021, 101564, ISSN 2210-7401. https://doi.org/10.1016/j.clinre.2020.11.001.
- Harris M, Guy D, Picchio C, White T, Rhodes T, Lazarus J. Conceptualising hepatitis C stigma: A thematic synthesis of qualitative research. International Journal of Drug Policy, Volume 96, 2021, 103320, ISSN 0955-3959, https://doi.org/10.1016/j.drugpo.2021.103320.